DNA mismatch repair deficiency tumour testing for patients with colorectal cancer Recommendations

Colorectal cancer (CRC) is the third most common cancer in men and the second in women worldwide. Approximately 3% to 5% of colorectal cancers are attributable to a hereditary cancer predisposition related to DNA mismatch repair (MMR) deficiency. Deficient MMR (dMMR) results in an inability to corre...

Full description

Bibliographic Details
Main Author: Canadian Agency for Drugs and Technologies in Health (author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Format: eBook
Language:Inglés
Published: Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health 2016.
Subjects:
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820280706719

Similar Items